This comprehensive, webinar-based training program is designed to meet the Substance Abuse and Mental Health Services Administration (SAMHSA) training requirements for Medication Access and Training Expansion (MATE) Act of 2023. Pharmacists and physicians initiating medications for opioid use disorder will learn about screening, non-pharmacologic and pharmacologic management and communication and addressing barriers related to management of pain and substance use disorders.